This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Patricia C. McCormack, MS, MD; Glenn N. Ledesma, MD; Juan G. Vaillant, MD
Department of Dermatology New York Medical College-Metropolitan Hospital Center New York, NY 10029

Arch Dermatol. 1984;120(6):708-709.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Goldman et al,¹ in the October 1981 ARCHIVES, reported a case of linear leukoderma without atrophy after intra-articular injection of a concentrated corticosteroid suspension. We report an additional case with subsequent spontaneous repigmentation that was not observed by the previous authors.

Report of a Case.—

A 51-year-old woman had had persistent pain around the region of the second and third metatarsophalangeal joints of her left foot. She was told that this was related to malalignment of her toes caused by a bunion. In May 1982, she had received a single corticosteroid injection presumably into the left second metatarsophalangeal joint with subsequent relief of pain. The suspension used was 40 mg/mL of triamcinolone (Aristocort) acetonide; the total amount injected was 1 mL. During the next month, the patient noted hypopigmentation of the skin around the site of injection without evidence of inflammation or atrophy. The hypopigmentation spread . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?